MONTREAL & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Valence Discovery (“Valence”), an emerging leader in AI-enabled drug design, today announced it has entered into a drug discovery agreement with Repare ...
Valence Surface Technologies LLC (“Valence”) is pleased to announce the acquisition of H&W Global Industries, Inc. (“H&W” or the “Company”), a leading provider of surface treatment for highly ...
Valence Labs is Recursion’s new machine learning research center that aims to promote open science and academic research. $1 million will be committed to advancing the next generation of academic ...
WILMINGTON, Mass. & MONTREAL--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and Valence Discovery today announced the formation of a strategic partnership to provide ...
Acquisition Bolsters Defense, Space, and Commercial Aerospace Surface Treatment Capabilities Valence Surface Technologies LLC (“Valence”), the largest independent aerospace surface finishing platform ...
SALT LAKE CITY and TORONTO and MONTRÉAL, May 08, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today ...
Latest funding led by Bessemer Venture Partners will accelerate continued expansion as the Fortune 500 rapidly scale AI coaching initiatives Valence is pioneering a new category of enterprise software ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results